{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T22:46:04Z","timestamp":1780353964839,"version":"3.54.1"},"reference-count":18,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2016,6,1]],"date-time":"2016-06-01T00:00:00Z","timestamp":1464739200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pathology"],"published-print":{"date-parts":[[2016,6]]},"DOI":"10.1016\/j.pathol.2016.03.012","type":"journal-article","created":{"date-parts":[[2016,4,30]],"date-time":"2016-04-30T20:24:28Z","timestamp":1462047868000},"page":"363-366","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":46,"title":["Diagnostic performance of a commercial immunoblot assay for myositis antibody testing"],"prefix":"10.1016","volume":"48","author":[{"given":"Chris","family":"Bundell","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arada","family":"Rojana-udomsart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Mastaglia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Hollingsworth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"McLean-Tooke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pathol.2016.03.012_bib1","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1016\/j.bbadis.2014.05.034","article-title":"Dermatomyositis, polymyositis and immune-mediated necrotising myopathies","volume":"1852","author":"Luo","year":"2015","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.pathol.2016.03.012_bib2","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1038\/nrrheum.2010.2","article-title":"Immunotherapy of myositis: issues, concerns and future prospects","volume":"6","author":"Dalakas","year":"2010","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.pathol.2016.03.012_bib3","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1007\/s11926-008-0053-2","article-title":"Autoantibodies and their significance in myositis","volume":"10","author":"Targoff","year":"2008","journal-title":"Curr Rheumatol Rep"},{"key":"10.1016\/j.pathol.2016.03.012_bib4","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1007\/s11926-014-0464-1","article-title":"Myositis specific and associated autoantibodies in the diagnosis and management of juvenile and adult idiopathic inflammatory myopathies","volume":"16","author":"Tansley","year":"2014","journal-title":"Curr Rheumatol Rep"},{"key":"10.1016\/j.pathol.2016.03.012_bib5","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/j.autrev.2014.03.004","article-title":"The clinical phenotype associated with myositis-specific and associated autoantibodies: a meta-analysis revisiting the so-called antisynthetase syndrome","volume":"13","author":"Lega","year":"2014","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.pathol.2016.03.012_bib6","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1111\/j.1756-185X.2011.01688.x","article-title":"South Australian Scleroderma Register: autoantibodies as predictive biomarkers of phenotype and outcome","volume":"15","author":"Graf","year":"2012","journal-title":"Int J Rheum Dis"},{"key":"10.1016\/j.pathol.2016.03.012_bib7","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.jbspin.2006.04.005","article-title":"Contribution of autoantibodies to the diagnosis and nosology of inflammatory muscle disease","volume":"73","author":"Sordet","year":"2006","journal-title":"Joint Bone Spine"},{"key":"10.1016\/j.pathol.2016.03.012_bib8","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1097\/01.bor.0000434664.37880.ac","article-title":"The diagnostic utility of autoantibodies in adult and juvenile myositis","volume":"25","author":"Tansley","year":"2013","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.pathol.2016.03.012_bib9","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.nmd.2004.02.006","article-title":"119th ENMC international workshop: trial design in adult idiopathic inflammatory myopathies, with the exception of inclusion body myositis, 10-12 October 2003, Naarden, The Netherlands","volume":"14","author":"Hoogendijk","year":"2004","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.pathol.2016.03.012_bib10","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/S1474-4422(07)70171-0","article-title":"Inclusion body myositis: current pathogenetic concepts and diagnostic and therapeutic approaches","volume":"6","author":"Needham","year":"2007","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.pathol.2016.03.012_bib11","series-title":"The Busselton Study: Mapping Population Health (Cardiovascular and Respiratory Disease Risk Factors in Busselton, Australia","year":"1998"},{"key":"10.1016\/j.pathol.2016.03.012_bib12","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.autrev.2009.02.012","article-title":"Commercial blot assays in the diagnosis of systemic rheumatic diseases","volume":"8","author":"Ghirardello","year":"2009","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.pathol.2016.03.012_bib13","doi-asserted-by":"crossref","first-page":"R22","DOI":"10.1186\/ar2614","article-title":"Antibodies against PM\/Scl-75 and PM\/Scl-100 are independent markers for different subsets of systemic sclerosis patients","volume":"11","author":"Hanke","year":"2009","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.pathol.2016.03.012_bib14","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1136\/ard.60.2.116","article-title":"Autoantibody profiles in the sera of European patients with myositis","volume":"60","author":"Brouwer","year":"2001","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.pathol.2016.03.012_bib15","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.autrev.2009.03.005","article-title":"Use of a commercial line blot assay as a screening test for autoantibodies in inflammatory myopathies","volume":"9","author":"Ronnelid","year":"2009","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.pathol.2016.03.012_bib16","doi-asserted-by":"crossref","first-page":"R78","DOI":"10.1186\/ar2276","article-title":"Heterogeneity of autoantibodies in 100 patients with autoimmune myositis: insights into clinical features and outcomes","volume":"9","author":"Koenig","year":"2007","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.pathol.2016.03.012_bib17","doi-asserted-by":"crossref","first-page":"909","DOI":"10.6061\/clinics\/2013(07)04","article-title":"Myositis-specific and myositis-associated autoantibody profiles and their clinical associations in a large series of patients with polymyositis and dermatomyositis","volume":"68","author":"Cruellas","year":"2013","journal-title":"Clinics (Sao Paulo)"},{"key":"10.1016\/j.pathol.2016.03.012_bib18","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1002\/mus.22279","article-title":"Necrotizing myopathy: clinicoserologic associations","volume":"45","author":"Ellis","year":"2012","journal-title":"Muscle Nerve"}],"container-title":["Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S003130251640084X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S003130251640084X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,12]],"date-time":"2018-09-12T12:20:12Z","timestamp":1536754812000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S003130251640084X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6]]},"references-count":18,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2016,6]]}},"alternative-id":["S003130251640084X"],"URL":"https:\/\/doi.org\/10.1016\/j.pathol.2016.03.012","relation":{},"ISSN":["0031-3025"],"issn-type":[{"value":"0031-3025","type":"print"}],"subject":[],"published":{"date-parts":[[2016,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Diagnostic performance of a commercial immunoblot assay for myositis antibody testing","name":"articletitle","label":"Article Title"},{"value":"Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pathol.2016.03.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Published by Elsevier B.V. on behalf of Royal College of Pathologists of Australasia.","name":"copyright","label":"Copyright"}]}}